{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T03:36:33Z","timestamp":1784432193562,"version":"3.55.0"},"reference-count":40,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National Center for Advancing Translational Sciences, National Institutes of Health","award":["UL1 TR000004"],"award-info":[{"award-number":["UL1 TR000004"]}]},{"name":"NCI","award":["CA151692"],"award-info":[{"award-number":["CA151692"]}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH"},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2022,6,13]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Little is known about hearing loss and tinnitus associated with neurotoxic chemotherapy. Study evaluated for differences in occurrence rates and effects of hearing loss and tinnitus in survivors who received a platinum alone, a taxane alone or a platinum and taxane containing regimen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Total of 273 survivors with breast, gastrointestinal, gynaecological or lung cancer completed self-report measures of hearing loss and tinnitus and had an audiometric assessment that obtained pure tone air conduction thresholds bilaterally at frequencies of between 0.25 kHz to 16.0\u2009kHz. To adjust for age-related and gender-related changes in hearing, each survivor\u2019s audiogram was evaluated using the National Health and Nutrition Examination Survey-modified Occupational Safety and Health Administration standards. Survivor was classified as having hearing loss if at any frequency they scored poorer than the 50th percentile for their age and gender. Survivors were categorised as having tinnitus if they reported that for<jats:underline>&gt;<\/jats:underline>10% of their time awake, they were consciously aware of their tinnitus. Differences among the chemotherapy groups were evaluated using parametric and non-parametric tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>For most of the demographic and clinical characteristics, no differences were found among the three chemotherapy groups. Occurrence rates for audiogram-confirmed hearing loss ranged from 52.3% to 71.4%. Occurrence rates for tinnitus ranged from 37.1% to 40.0%. No differences were found among the three chemotherapy groups in the occurrence rates or effects of hearing loss and tinnitus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings suggest that regardless of the chemotherapy regimen common mechanistic pathway(s) may underlie these two neurotoxicities.<\/jats:p><\/jats:sec>","DOI":"10.1136\/spcare-2022-003684","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T05:57:34Z","timestamp":1658987854000},"page":"345-353","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Cancer survivors and neurotoxic chemotherapy: hearing loss and tinnitus"],"prefix":"10.1136","volume":"13","author":[{"given":"Steven","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Henderson-Sabes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Mastick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Snowberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emely","family":"Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Wallhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5170-2027","authenticated-orcid":false,"given":"Christine","family":"Miaskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"2024051713062220000_13.3.345.1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051266","article-title":"Assessment and management of platinum-related ototoxicity in children treated for cancer","volume":"12","author":"Romano","year":"2020","journal-title":"Cancers"},{"key":"2024051713062220000_13.3.345.2","doi-asserted-by":"publisher","DOI":"10.1159\/000093776"},{"key":"2024051713062220000_13.3.345.3","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.226"},{"key":"2024051713062220000_13.3.345.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.9599"},{"key":"2024051713062220000_13.3.345.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.8822"},{"key":"2024051713062220000_13.3.345.6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.6004\/jnccn.2019.7369","article-title":"Testicular cancer survivorship","volume":"17","author":"Fung","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"2024051713062220000_13.3.345.7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/AUD.0000000000001172","article-title":"Ototoxicity after cisplatin-based chemotherapy: factors associated with discrepancies between patient-reported outcomes and audiometric assessments","volume":"43","author":"Ardeshirrouhanifard","year":"2022","journal-title":"Ear Hear"},{"key":"2024051713062220000_13.3.345.8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12032-015-0646-3","article-title":"Short-Term cohort study on sensorineural hearing changes in head and neck radiotherapy","volume":"32","author":"Cheraghi","year":"2015","journal-title":"Med Oncol"},{"key":"2024051713062220000_13.3.345.9","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1997.01900090094014"},{"key":"2024051713062220000_13.3.345.10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00930","article-title":"Quality of life, toxicity and unmet needs in nasopharyngeal cancer survivors","volume":"10","author":"McDowell","year":"2020","journal-title":"Front Oncol"},{"key":"2024051713062220000_13.3.345.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2013.05.006"},{"key":"2024051713062220000_13.3.345.12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2217\/pgs.11.48","article-title":"Pharmacogenomics of cisplatin-induced ototoxicity","volume":"12","author":"Mukherjea","year":"2011","journal-title":"Pharmacogenomics"},{"key":"2024051713062220000_13.3.345.13","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju044","article-title":"Chemotherapy-Induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics","volume":"106","author":"Travis","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2024051713062220000_13.3.345.14","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1111\/bph.15086","article-title":"Taxane-induced neurotoxicity: pathophysiology and therapeutic perspectives","volume":"177","author":"da Costa","year":"2020","journal-title":"Br J Pharmacol"},{"key":"2024051713062220000_13.3.345.15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.taap.2014.08.022","article-title":"Ototoxicity of paclitaxel in rat cochlear organotypic cultures","volume":"280","author":"Dong","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"2024051713062220000_13.3.345.16","first-page":"155","article-title":"Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect","volume":"22","author":"Salvinelli","year":"2003","journal-title":"J Exp Clin Cancer Res"},{"key":"2024051713062220000_13.3.345.17","first-page":"239","article-title":"Paraclinical evaluation of side-effects of taxanes on auditory system","volume":"28","author":"Sarafraz","year":"2008","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"2024051713062220000_13.3.345.18","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-00009577-200307000-00005"},{"key":"2024051713062220000_13.3.345.19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.breast.2009.07.004","article-title":"Hearing sensitivity in women following chemotherapy treatment for breast cancer: results from a pilot study","volume":"18","author":"Jenkins","year":"2009","journal-title":"Breast"},{"key":"2024051713062220000_13.3.345.20","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1080\/15384047.2020.1831370","article-title":"Ototoxicity in patients with invasive ductal breast cancer who were treated with docetaxel: report of two cases","volume":"21","author":"Xuan","year":"2020","journal-title":"Cancer Biol Ther"},{"key":"2024051713062220000_13.3.345.21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ygyno.2017.02.006","article-title":"Long-Term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer","volume":"145","author":"Skalleberg","year":"2017","journal-title":"Gynecol Oncol"},{"key":"2024051713062220000_13.3.345.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60142-7"},{"key":"2024051713062220000_13.3.345.23","doi-asserted-by":"publisher","DOI":"10.3109\/14992027.2010.551220"},{"key":"2024051713062220000_13.3.345.24","unstructured":"Karnofsky D . Performance scale. New York: Plenum Press, 1977."},{"key":"2024051713062220000_13.3.345.25","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-9-92","article-title":"Complex regional pain syndrome 1--the Swiss cohort study","volume":"9","author":"Brunner","year":"2008","journal-title":"BMC Musculoskelet Disord"},{"key":"2024051713062220000_13.3.345.26","doi-asserted-by":"publisher","DOI":"10.1097\/00003446-199110000-00009"},{"key":"2024051713062220000_13.3.345.27","doi-asserted-by":"publisher","DOI":"10.3109\/14992020903092608"},{"key":"2024051713062220000_13.3.345.28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.heares.2015.06.004","article-title":"Tinnitus functional index: development, validation, outcomes research, and clinical application","volume":"334","author":"Henry","year":"2016","journal-title":"Hear Res"},{"key":"2024051713062220000_13.3.345.29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-007561"},{"key":"2024051713062220000_13.3.345.30","doi-asserted-by":"publisher","DOI":"10.1097\/AUD.0b013e3181e9770e"},{"key":"2024051713062220000_13.3.345.31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pbr.2020.12.002","article-title":"Tinnitus and tinnitus disorder: theoretical and operational definitions (an international multidisciplinary proposal)","volume":"260","author":"De Ridder","year":"2021","journal-title":"Prog Brain Res"},{"key":"2024051713062220000_13.3.345.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2024051713062220000_13.3.345.33","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/jama.2021.2566","article-title":"Screening for hearing loss in older adults: US preventive services Task force recommendation statement","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA"},{"key":"2024051713062220000_13.3.345.34","first-page":"1","article-title":"Self-Reported hearing trouble in adults aged 18 and over: United States, 2014","volume":"214","author":"Zelaya","year":"2015","journal-title":"NCHS Data Brief"},{"key":"2024051713062220000_13.3.345.35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.15009","article-title":"Comparison of self-reported measures of hearing with an objective audiometric measure in adults in the English longitudinal study of ageing","volume":"3","author":"Tsimpida","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024051713062220000_13.3.345.36","doi-asserted-by":"publisher","DOI":"10.1097\/00003446-199012000-00004"},{"key":"2024051713062220000_13.3.345.37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/14992027.2018.1461262","article-title":"Hearing loss and social support in urban and rural communities","volume":"57","author":"Hay-McCutcheon","year":"2018","journal-title":"Int J Audiol"},{"key":"2024051713062220000_13.3.345.38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14992027.2020.1858237","article-title":"Self-reported hearing handicap in adults aged 55 to 81 years is modulated by hearing abilities, frailty, mental health, and willingness to use hearing AIDS","volume":"60","author":"Nuesse","year":"2021","journal-title":"Int J Audiol"},{"key":"2024051713062220000_13.3.345.39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/7854_2020_154","article-title":"Prevalence, incidence, and risk factors for tinnitus","volume":"51","author":"Biswas","year":"2021","journal-title":"Curr Top Behav Neurosci"},{"key":"2024051713062220000_13.3.345.40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01632-5","article-title":"Differences in characteristics between people with tinnitus that seek help and that do not","volume":"11","author":"Rademaker","year":"2021","journal-title":"Sci Rep"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2022-003684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:36:21Z","timestamp":1715985381000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2022-003684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,8,18]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/spcare-2022-003684"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2022-003684","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]}}}